{"title":"神经退行性疾病。","authors":"A. Hannan","doi":"10.5772/45957","DOIUrl":null,"url":null,"abstract":"Although this meeting included thousands of presentations spanning the full diversity of neuroscience at the millennium, this report focuses on pharmacological developments of relevance to neurodegenerative diseases.","PeriodicalId":55031,"journal":{"name":"Idrugs","volume":"29 1","pages":"6-8"},"PeriodicalIF":0.0000,"publicationDate":"2023-03-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Neurodegenerative diseases.\",\"authors\":\"A. Hannan\",\"doi\":\"10.5772/45957\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Although this meeting included thousands of presentations spanning the full diversity of neuroscience at the millennium, this report focuses on pharmacological developments of relevance to neurodegenerative diseases.\",\"PeriodicalId\":55031,\"journal\":{\"name\":\"Idrugs\",\"volume\":\"29 1\",\"pages\":\"6-8\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-03-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Idrugs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.5772/45957\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Idrugs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5772/45957","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Although this meeting included thousands of presentations spanning the full diversity of neuroscience at the millennium, this report focuses on pharmacological developments of relevance to neurodegenerative diseases.